Regencell Bioscience (RGC) Institutional Ownership $12.80 +0.24 (+1.91%) As of 08/22/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Regencell Bioscience (NASDAQ:RGC)CurrentInstitutional OwnershipPercentage0.13%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$9.43MNumber ofInstitutional Sellers(last 12 months)0 Get RGC Insider Trade Alerts Want to know when executives and insiders are buying or selling Regencell Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RGC Institutional Buying and Selling by Quarter Regencell Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 BNP Paribas Financial Markets45,050$768K0.0%N/A0.000% 8/14/2025 Squarepoint Ops LLC99,843$1.70M0.0%N/A0.000% 8/8/2025 Geode Capital Management LLC391,066$6.66M0.0%+5,637.5%0.000% 8/1/2025 Y Intercept Hong Kong Ltd13,042$222K0.0%N/A0.003% 7/7/2025 Greenfield Savings Bank11,000$187K0.1%N/A0.000% (Data available from 1/1/2016 forward) RGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RGC shares? During the previous two years, the following institutional investors and hedge funds held shares of Regencell Bioscience shares: Geode Capital Management LLC ($6.66M), Squarepoint Ops LLC ($1.70M), BNP Paribas Financial Markets ($768K), and Y Intercept Hong Kong Ltd ($222K), Greenfield Savings Bank ($187K).Learn more on Regencell Bioscience's institutional investors. What percentage of Regencell Bioscience's stock is owned by institutional investors? 0.13% of Regencell Bioscience's stock is owned by institutional investors. Learn more on RGC's institutional investor holdings. Which institutional investors have been buying Regencell Bioscience's stock? The following institutional investors have purchased Regencell Bioscience's stock in the last 24 months: Geode Capital Management LLC ($384.25K), Squarepoint Ops LLC ($99.84K), BNP Paribas Financial Markets ($45.05K), Y Intercept Hong Kong Ltd ($13.04K), and Greenfield Savings Bank ($11K). How much institutional buying is happening at Regencell Bioscience? Institutional investors have bought a total of 553,185 shares in the last 24 months. This purchase volume represents approximately $9.43M in transactions. Related Companies GLPG Institutional Ownership INDV Institutional Ownership INCR Institutional Ownership NERV Institutional Ownership NTHI Institutional Ownership This page (NASDAQ:RGC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regencell Bioscience Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Regencell Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access